Catalyst Wire Dossier Catalyst Wire Dossier

Soluble human insulin

human insulin (regular) · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Soluble human insulin, covering 2016-10-28 to 2016-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes

See pricing